L’immunothérapie des cancers chez les personnes vivant avec le VIH (notice n° 270949)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01862cam a2200349 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112080430.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Spano, Jean-Philippe |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | L’immunothérapie des cancers chez les personnes vivant avec le VIH |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2019.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 21 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméBien que les personnes vivant avec le VIH (PVVIH) aient été exclues de la plupart des essais cliniques d’immunothérapie, l’utilisation des inhibiteurs des points de contrôle immunitaire est tout à fait possible dans cette population. Des essais spécifiques sont en cours et pourront confirmer que le profil de tolérance et l’efficacité de ces traitements sont similaires à ceux de la population générale. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Although persons living with HIV have been excluded from most immunotherapy clinical trials, it is possible to use checkpoint inhibitors (CPIs) in this population. Specific trials are ongoing and may confirm that the safety profile and efficacy of these treatments are similar to those in the general population. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | essai clinique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | inhibiteurs des points de contrôle immunitaire |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | VIH |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | HIV |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | clinical trial |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | immune checkpoint inhibitors |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Veyri, Marianne |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Abbar, Baptiste |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lavolé, Armelle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baron, Marine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guihot, Amélie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Poizot-Martin, Isabelle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Katlama, Christine |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Innovations & Thérapeutiques en Oncologie | Volume 5 | 3 | 2019-05-01 | p. 149-151 | 2431-3203 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2019-3-page-149?lang=fr">https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2019-3-page-149?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux